Serum levels of asymmetric dimethylarginine (ADMA) exhibit sharp decline from childhood to adolescence, which is attenuated in obesity and type I diabetes

S Pilz; Holger Hubmann; Andreas Meinitzer; Helmuth Martin Borkenstein; Harald Mangge

Serum levels of asymmetric dimethylarginine (ADMA) exhibit sharp decline from childhood to adolescence, which is attenuated in obesity and type I diabetes

Research output: Contribution to journal › Conference abstract

Original language	English
Journal	Atherosclerosis Plus
Publication status	Published - 2004
Event	74th Congress of the European Atherosclerosis Society - Seville, Spain Duration: 17 Apr 2004 → 20 Apr 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Branches of science

301 Medical-Theoretical Sciences, Pharmacy
302 Clinical Medicine
104 Chemistry

Cite this

@article{2b857a499f12428199ae309c71ae54db,

title = "Serum levels of asymmetric dimethylarginine (ADMA) exhibit sharp decline from childhood to adolescence, which is attenuated in obesity and type I diabetes",

author = "S Pilz and Holger Hubmann and Andreas Meinitzer and Borkenstein, \{Helmuth Martin\} and Harald Mangge",

year = "2004",

language = "English",

journal = "Atherosclerosis Plus",

issn = "2667-0909",

publisher = "Elsevier Ireland Ltd",

note = "74th Congress of the European Atherosclerosis Society, EAS 74 ; Conference date: 17-04-2004 Through 20-04-2004",

}

TY - JOUR

T1 - Serum levels of asymmetric dimethylarginine (ADMA) exhibit sharp decline from childhood to adolescence, which is attenuated in obesity and type I diabetes

AU - Pilz, S

AU - Hubmann, Holger

AU - Meinitzer, Andreas

AU - Borkenstein, Helmuth Martin

AU - Mangge, Harald

PY - 2004

Y1 - 2004

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000221639000145

M3 - Conference abstract

SN - 2667-0909

JO - Atherosclerosis Plus

JF - Atherosclerosis Plus

T2 - 74th Congress of the European Atherosclerosis Society

Y2 - 17 April 2004 through 20 April 2004

ER -

Serum levels of asymmetric dimethylarginine (ADMA) exhibit sharp decline from childhood to adolescence, which is attenuated in obesity and type I diabetes

UN SDGs

Branches of science

Links

Cite this